Drug recall D-0191-2024
Product
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 45963-676-96
Reason for recall
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Lots and codes
Batch 2447J211
Recall details
- Recalling firm
- CARDINAL HEALTHCARE, Dublin, OH
- Quantity
- 1 unit
- Distribution
- Nationwide USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 26, 2022
- Terminated
- September 29, 2024
Related products
- Metoprolol Succinate – drug information
- NDC 45963-709 Metoprolol succinate · Metoprolol Succinate 25 mg/1 · Actavis Pharma, Inc.
- NDC 45963-677 Metoprolol succinate · Metoprolol Succinate 100 mg/1 · Actavis Pharma, Inc.
- NDC 45963-678 Metoprolol succinate · Metoprolol Succinate 200 mg/1 · Actavis Pharma, Inc.
- NDC 45963-676 Metoprolol succinate · Metoprolol Succinate 50 mg/1 · Actavis Pharma, Inc.